RP
Ramjee Pallela
About Ramjee Pallela
Data last updated:
Ramjee Pallela is a Director at Avishkaran-Foundation For Pharma Innovation (since 2023). The company operates in Pharma. Avishkaran-Foundation For Pharma Innovation reported revenue of ₹56.8 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Avishkaran-Foundation For Pharma Innovation U85300TG2021NPL149258 | Director | 14 Dec 2023 | 2021 | ₹56.8 Lakh (FY 2025) | Active |
Board colleagues of Ramjee Pallela
| Name | DIN | Company | Designation |
|---|---|---|---|
| Anand Govindaluri | 01011788 | Avishkaran-Foundation For Pharma Innovation | Director |
| Anil Wali | 08177259 | Avishkaran-Foundation For Pharma Innovation | Director |
| Gananadhamu Samanthula | 09090803 | Avishkaran-Foundation For Pharma Innovation | Director |
| Nanduri Srinivas | 09090702 | Avishkaran-Foundation For Pharma Innovation | Director |
| Padmaja Surapureddy | 05358127 | Avishkaran-Foundation For Pharma Innovation | Director |
| Saurabh Srivastava | 09767233 | Avishkaran-Foundation For Pharma Innovation | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ramjee Pallela
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ramjee Pallela
Ramjee Pallela currently holds 1 directorship: Avishkaran-Foundation For Pharma Innovation (Director, since 14 Dec 2023, revenue ₹56.8 Lakh (FY 2025)).
Ramjee Pallela was first appointed on 14 Dec 2023 as Director at Avishkaran-Foundation For Pharma Innovation.
The current boards of Ramjee Pallela's companies include Anand Govindaluri (Avishkaran-Foundation For Pharma Innovation), Anil Wali (Avishkaran-Foundation For Pharma Innovation), Gananadhamu Samanthula (Avishkaran-Foundation For Pharma Innovation), Nanduri Srinivas (Avishkaran-Foundation For Pharma Innovation), Padmaja Surapureddy (Avishkaran-Foundation For Pharma Innovation), Saurabh Srivastava (Avishkaran-Foundation For Pharma Innovation).